| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 12/12/2012 | CN102813338A Paper insole for treating beriberi |
| 12/12/2012 | CN102389560B Traditional Chinese medicine used for treating epidemic encephalitis type B |
| 12/12/2012 | CN102349984B External drug for treating beriberi, foot odor and hircismus |
| 12/12/2012 | CN102293785B Method for extracting secondary metabolites of insects or arthropods |
| 12/12/2012 | CN102240286B Application of matrine to medicament for treating or preventing enterovirus 71 type infection |
| 12/12/2012 | CN102228482B Propolis injection for preventing duck hemorrhagic oophoritis and preparation method thereof |
| 12/12/2012 | CN102178713B Panax notoginseng extract with antibacterial pharmacological activity as well as preparation method and application thereof |
| 12/12/2012 | CN102144975B Cefprozil suspension pharmaceutical composition |
| 12/12/2012 | CN102140460B SiRNA (Small interference ribonucleic acid) as well as medicine composition and pharmaceutical application thereof |
| 12/12/2012 | CN102100818B Quality control method for lophanthus antifebrile tablets |
| 12/12/2012 | CN102099027B Fulvic acid and antibiotic combination |
| 12/12/2012 | CN102048747B Tulathromycin composition used for treating or preventing pet bacterial diseases and preparation method thereof |
| 12/12/2012 | CN102040595B 1,3,4-hiadiazine derivatives as well as preparation method and application thereof |
| 12/12/2012 | CN102038725B Composition for prevention of influenza viral infection comprising sumac extract, air filter comprising the same and air cleaning device comprising the filter |
| 12/12/2012 | CN102000328B Method for manufacturing Marek's disease vaccine by utilizing cell factory |
| 12/12/2012 | CN101974489B A H1N1 influenza virus and application thereof |
| 12/12/2012 | CN101920012B Method for producing porcine circovirus type II recombinant capsid protein subunit vaccine by utilizing silkworm bioreactor and products thereof |
| 12/12/2012 | CN101875648B Method for extracting and purifying Pinostrobin from medicinal plants, and pharmaceutical preparation and application thereof |
| 12/12/2012 | CN101863876B Fluoroquinolone comprising 7-(3-amino-4-oximido)-1-piperidyl substitutional group and application of composition thereof |
| 12/12/2012 | CN101837117B Application of B cell epitope peptide from tetanus exotoxin fragment C |
| 12/12/2012 | CN101829321B Vaccine for preventing red head disease of Pseudobagrus fulvidraco |
| 12/12/2012 | CN101829113B Application of berberine in medicine for treating or preventing influenza virus |
| 12/12/2012 | CN101786979B (+/-)-marinopyrrole A for resisting methicillin-resistant staphylococcus aureus (MRSA) and synthesized derivative thereof |
| 12/12/2012 | CN101732710B Foot and mouth disease virus inhibitor and preparation method and application thereof |
| 12/12/2012 | CN101500584B Use of micron sulfur in prevention and treatment for pathogenic disorder of human or animal |
| 12/12/2012 | CN101492456B Coumarin ether compounds and new use of composition |
| 12/12/2012 | CN101365708B Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1h-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1h-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine |
| 12/12/2012 | CN101305019B 新的环肽化合物 The new cyclic peptide compound |
| 12/12/2012 | CN101239989B Nucleotide analog |
| 12/11/2012 | US8332159 Method for enhancing efficacy of preparation of monoclonal antibody |
| 12/11/2012 | US8329928 Compounds, compositions and methods |
| 12/11/2012 | US8329908 Dual action antibiotics |
| 12/11/2012 | US8329900 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 12/11/2012 | US8329742 Macrocyclic compounds useful as pharmaceuticals |
| 12/11/2012 | US8329712 Heterocyclic antiviral compounds |
| 12/11/2012 | US8329662 Prodrug of an ICE inhibitor |
| 12/11/2012 | US8329658 Arylalkyl and heteroarylalkyl derivatives of cyclosporine A for the treatment and prevention of viral infection |
| 12/11/2012 | US8329643 PIMAP39 modulates LPS-induced inflammatory response |
| 12/11/2012 | US8329639 MUC1 based glycolipopeptide vaccine with adjuvant |
| 12/11/2012 | US8329466 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 12/11/2012 | US8329463 RNA interference mediating small RNA molecules |
| 12/11/2012 | US8329194 Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD) |
| 12/11/2012 | US8329190 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| 12/11/2012 | US8329163 Attenuated gram negative bacteria |
| 12/11/2012 | US8329159 Hepatitis C virus inhibitors |
| 12/11/2012 | CA2721440C Crystalline (6r,7r)-7-{2-(5-amino-[1,2,4]thiadiazol-3-yl)-2-[(z)-trityloxyimino]-acetylamino}-3-[(r)-1'-tert-butoxycarbonyl-2-oxo-[1,3']bipyrrolidinyl-(3e)-ylidenemethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester; its manufacture and use |
| 12/11/2012 | CA2698221C Compositions comprising quinolone and methods for treating or controlling infections |
| 12/11/2012 | CA2639048C Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |
| 12/11/2012 | CA2524534C Methods and compositions for the prevention and treatment of sepsis |
| 12/11/2012 | CA2503871C An immunogenic composition for generating an immune response against polio virus |
| 12/11/2012 | CA2481479C Novel flavivirus antigens |
| 12/11/2012 | CA2388054C Compositions and methods for stimulating an immune response against infectious agents |
| 12/11/2012 | CA2284459C Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 12/06/2012 | WO2012167237A2 Compounds having antiparasitic or anti-infectious activity |
| 12/06/2012 | WO2012167081A1 Hydrazino 1h-imidazoquinolin-4-amines and conjugates made therefrom |
| 12/06/2012 | WO2012166859A2 Modulation of sphingosine 1-phosphate metabolizing enzymes for the treatment of negative-strand rna virus infections |
| 12/06/2012 | WO2012166716A2 Subsituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections |
| 12/06/2012 | WO2012166665A2 Broad spectrum antibiotics |
| 12/06/2012 | WO2012166459A1 Tripeptides incorporating deuterium as inhibitors of hepatitis c virus |
| 12/06/2012 | WO2012165854A2 Long interfering dsrna simultaneously inducing an immune reaction and the inhibition of the expression of target genes |
| 12/06/2012 | WO2012165542A1 Mutant replicon derived from genome of hepatitis c virus j6cf strain |
| 12/06/2012 | WO2012164928A1 H5n1 influenza vaccine and kit for protection against infection |
| 12/06/2012 | WO2012164572A1 Substituted 4-arylthiazoles and process of preparation thereof |
| 12/06/2012 | WO2012164508A1 Strain of cobetia marina and biosurfactant extract obtained from same |
| 12/06/2012 | WO2012164480A1 A vaccine composition capable of inducing memory antibody response from single point immunization |
| 12/06/2012 | WO2012164372A1 Recombinant anti-canine parvovirus antibody and uses thereof |
| 12/06/2012 | WO2012164241A1 Pharmaceutical antiretroviral composition |
| 12/06/2012 | WO2012164118A1 Bioactive polyphenolic compounds containing sulphur or selenium and uses thereof |
| 12/06/2012 | WO2012163289A1 Fusion protein comprising diphtheria toxin non-toxic mutant crm197 or fragment thereof |
| 12/06/2012 | WO2012163258A1 Combined vaccines for prevention of porcine virus infections |
| 12/06/2012 | WO2012163174A1 Pharmaceutical use of 2-(4-morpholinoaniline)-6-cyclohexyl aminopurine and pharmaceutically acceptable salt or derivative thereof |
| 12/06/2012 | WO2012162912A1 Benzothiazinethione derivatives and their preparative methods and uses |
| 12/06/2012 | WO2012162828A1 Matriptase inhibitors and uses thereof against orthomyxoviridae infections |
| 12/06/2012 | WO2012162814A1 Novel antibacterial combination therapy |
| 12/06/2012 | WO2012090205A3 Plant extracts for the treatment and prevention of infections |
| 12/06/2012 | WO2012078559A3 Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same |
| 12/06/2012 | US20120309843 Highly permeating terbinafine formulation |
| 12/06/2012 | US20120309836 Methods and compositions for administration of trpv1 agonists |
| 12/06/2012 | US20120309822 Treatment of infectious diseases |
| 12/06/2012 | US20120309813 DELIVERY OF dsRNA TO ARTHROPODS |
| 12/06/2012 | US20120309811 P-glycoprotein-specific non-competitive peptide and peptidomimetic modulators |
| 12/06/2012 | US20120309807 Methods and compositions related to regulation of cytokine production by glycogen synthase kinase 3 (gsk-3) |
| 12/06/2012 | US20120309801 Calixarene-based peptide conformation mimetics, methods of use, and methods of making |
| 12/06/2012 | US20120309800 Metalloenzyme inhibitor compounds |
| 12/06/2012 | US20120309771 Novel antifungal triazole derivatives |
| 12/06/2012 | US20120309770 Compounds for the Treatment of Hepatitis C |
| 12/06/2012 | US20120309763 Antifungal composition intended to be applied to a perforated nail |
| 12/06/2012 | US20120309762 Cytochrome p450 oxidase inhibitors and uses thereof |
| 12/06/2012 | US20120309753 Method of dissolving antifungal agent, and compositions with a high concentration of antifungal agent, suitable for application to the nail |
| 12/06/2012 | US20120309751 Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof |
| 12/06/2012 | US20120309747 Protein kinase inhibitors |
| 12/06/2012 | US20120309745 HIV Integrase Inhibitors |
| 12/06/2012 | US20120309733 Composition |
| 12/06/2012 | US20120309720 Compositions and methods for treatment of glaucoma |
| 12/06/2012 | US20120309709 Ion-Channel Regulator Compositions and Methods of Using Same |
| 12/06/2012 | US20120309705 Novel 3'-deoxy-3'-methylidene-beta-l-nucleosides |
| 12/06/2012 | US20120309701 Compounds and methods for treating bacterial infections |
| 12/06/2012 | US20120309698 HIV Integrase Inhibitors |
| 12/06/2012 | US20120309676 Lantibiotic Salts |
| 12/06/2012 | US20120309628 Bioactive agent delivery particles |